MC1424A1 - Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique - Google Patents

Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique

Info

Publication number
MC1424A1
MC1424A1 MC811558A MC1558A MC1424A1 MC 1424 A1 MC1424 A1 MC 1424A1 MC 811558 A MC811558 A MC 811558A MC 1558 A MC1558 A MC 1558A MC 1424 A1 MC1424 A1 MC 1424A1
Authority
MC
Monaco
Prior art keywords
leif
amino acids
terminal portion
consists essentially
fragment
Prior art date
Application number
MC811558A
Other languages
English (en)
French (fr)
Inventor
Goeddel David Van Norman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MC1424A1 publication Critical patent/MC1424A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MC811558A 1980-11-10 1981-11-09 Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique MC1424A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (1)

Publication Number Publication Date
MC1424A1 true MC1424A1 (fr) 1982-10-18

Family

ID=27394813

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811558A MC1424A1 (fr) 1980-11-10 1981-11-09 Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique

Country Status (34)

Country Link
EP (1) EP0051873B1 (da)
JP (1) JP2642291B2 (da)
KR (1) KR920007439B1 (da)
AT (1) ATE46718T1 (da)
AU (1) AU555293B2 (da)
BR (1) BR8107293A (da)
CA (2) CA1212915A (da)
CH (2) CH660743A5 (da)
DE (2) DE3177106D1 (da)
DK (1) DK173590B1 (da)
DO (1) DOP1981004064A (da)
DZ (1) DZ350A1 (da)
ES (2) ES8302778A1 (da)
FI (1) FI79550C (da)
FR (1) FR2493867B1 (da)
GB (1) GB2090258B (da)
GR (1) GR81947B (da)
HK (1) HK51685A (da)
IE (1) IE51850B1 (da)
IL (1) IL64243A (da)
IT (1) IT1169276B (da)
KE (1) KE3536A (da)
LU (1) LU83745A1 (da)
MC (1) MC1424A1 (da)
MY (2) MY8700710A (da)
NL (1) NL189092C (da)
NO (1) NO165201C (da)
NZ (1) NZ198906A (da)
PH (1) PH18565A (da)
PL (1) PL233748A1 (da)
PT (1) PT73955B (da)
SE (1) SE460539B (da)
YU (1) YU46597B (da)
ZW (1) ZW26981A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
EP0072541A3 (en) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1983002461A1 (en) * 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
JPS60500574A (ja) * 1983-02-24 1985-04-25 インステイチユト　オルガニチエスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスア−ル ヒト白血球インタ−フェロンｎ及び細菌細胞におけるその製造方法
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (en) * 1984-08-31 1986-03-12 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE78262T1 (de) * 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst Pulmonary surfactant proteins.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
CA2223088A1 (en) 1995-06-07 1996-12-19 Bob Dale Brown Novel carbamate-based cationic lipids
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
WO2004022593A2 (en) 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
WO2005113592A2 (en) 2004-05-19 2005-12-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA2607651A1 (en) 2005-05-18 2007-04-19 Maxygen, Inc. Evolved interferon-alpha polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides

Also Published As

Publication number Publication date
NL8105078A (nl) 1982-06-01
PL233748A1 (en) 1983-07-18
ATE46718T1 (de) 1989-10-15
SE8106641L (sv) 1982-06-24
FI79550B (fi) 1989-09-29
ES506955A0 (es) 1983-02-01
ZW26981A1 (en) 1982-06-02
EP0051873A3 (en) 1982-09-22
NO165201C (no) 1991-01-16
KE3536A (en) 1985-06-07
NL189092C (nl) 1993-01-04
GB2090258A (en) 1982-07-07
PH18565A (en) 1985-08-09
IL64243A (en) 1985-11-29
PT73955A (en) 1981-12-01
DOP1981004064A (es) 1988-03-16
JPH07308191A (ja) 1995-11-28
ES8304200A1 (es) 1983-03-01
NO813785L (no) 1982-05-11
DZ350A1 (fr) 2004-09-13
NZ198906A (en) 1985-12-13
AU555293B2 (en) 1986-09-18
KR920007439B1 (ko) 1992-09-01
DE3177106D1 (en) 1989-11-02
FI813539L (fi) 1982-05-11
EP0051873B1 (en) 1989-09-27
ES8302778A1 (es) 1983-02-01
LU83745A1 (de) 1983-09-01
NO165201B (no) 1990-10-01
KR830007825A (ko) 1983-11-07
MY8700710A (en) 1987-12-31
YU265681A (en) 1984-08-31
BR8107293A (pt) 1982-08-03
HK51685A (en) 1985-07-12
IE51850B1 (en) 1987-04-15
AU7730481A (en) 1982-05-20
FI79550C (fi) 1990-01-10
CA1277616C (en) 1990-12-11
IE812622L (en) 1982-05-10
FR2493867B1 (fr) 1986-06-27
GR81947B (da) 1984-12-12
IL64243A0 (en) 1982-02-28
GB2090258B (en) 1984-05-02
JP2642291B2 (ja) 1997-08-20
DE3144469A1 (de) 1982-09-02
CH660743A5 (de) 1987-06-15
EP0051873A2 (en) 1982-05-19
DK173590B1 (da) 2001-04-02
CA1212915A (en) 1986-10-21
NL189092B (nl) 1992-08-03
YU46597B (sh) 1994-01-20
ES512354A0 (es) 1983-03-01
FR2493867A1 (fr) 1982-05-14
CH663032A5 (de) 1987-11-13
PT73955B (en) 1983-11-23
SE460539B (sv) 1989-10-23
IT1169276B (it) 1987-05-27
IT8124967A0 (it) 1981-11-10
DK494681A (da) 1982-05-11
MY8800066A (en) 1988-12-31

Similar Documents

Publication Publication Date Title
FR2493867A1 (fr) Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique
US4678751A (en) Hybrid human leukocyte interferons
US4456748A (en) Hybrid human leukocyte interferons
MC1396A1 (fr) Interferons et procede pour leur preparation
MC1423A1 (fr) Production microbienne d'interferon de fibroplaste humain
BE898016A (fr) Muteines appauvries en cysteine provenant de proteines biologiquement actives.
CH672790A5 (da)
HU193512B (en) Process for preparing hybride interferones from human erythrocytes
FR2481316A1 (fr) Technique a adn de recombinant pour la preparation d'une proteine ressemblant a l'interferon humain
JPH064673B2 (ja) ハイブリド型ヒト白血球インタフエロン
KR910009901B1 (ko) 하이브리드 인간 백혈구 인터페론
AT394210B (de) Verfahren zur herstellung von doppelstraengiger dna kodierend fuer hybride human-leukozyten-interferone
KR870000510B1 (ko) 형질전환된 미생물의 제조방법
FI82714C (fi) Foerfarande foer framstaellning av en transformerad stam av e.coli, som foermaor expressera ett humant moget leukocytinterferon.
JPH066066B2 (ja) 遺伝子組換体の産生する生理活性物質の熱処理法
CH669394A5 (en) Synthetic protein analogues lacking cysteine residues
NO165555B (no) Kunstig hybrid humant leukocytt-interferon-kodende dna-sekvens.
JPH01165399A (ja) 組換えヒトインターロイキン２およびその製造法
JPH01157394A (ja) ヒトインターロイキン２活性をもつポリペプチドをコードする遺伝子を含有する発現ベクターおよび該ベクターにより形質転換された真核生物
IL63197A (en) Intraferons for mature human oocytes, their preparation and preparations containing them

Legal Events

Date Code Title Description
YP Annual fee paid